(Q33355394)

26 July 2017

A phase II study of triazinate (NSC 139105) in advanced colorectal carcinoma (English)

1 reference

10.1002/1097-0142(197707)40:1<9::AID-CNCR2820400104>3.0.CO;2-6

26 July 2017

1 reference

1 reference

https://api.crossref.org/works/10.1002/1097-0142(197707)40:1%3C9::AID-CNCR2820400104%3E3.0.CO;2-6

14 December 2022

author name string

R. H. McCreary

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A141977

14 December 2022

C. G. Moertel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A141977

14 December 2022

A. J. Schutt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A141977

14 December 2022

M. J. O'Connell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A141977

14 December 2022

R. G. Hahn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A141977

14 December 2022

R. J. Reitemeier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A141977

14 December 2022

J. Rubin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A141977

14 December 2022

S. Frytak

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A141977

14 December 2022

language of work or name

English

0 references

publication date

1 July 1977

1 reference

full work available at URL

26 July 2017

5

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197707)40:1%3C9::AID-CNCR2820400104%3E3.0.CO;2-6

1 reference

10.1002/1097-0142(197707)40:1<9::AID-CNCR2820400104>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197707)40:1%3C9::AID-CNCR2820400104%3E3.0.CO;2-6

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197707)40:1%3C9::AID-CNCR2820400104%3E3.0.CO;2-6

14 December 2022

1 reference

10.1002/1097-0142(197707)40:1<9::AID-CNCR2820400104>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197707)40:1%3C9::AID-CNCR2820400104%3E3.0.CO;2-6

14 December 2022

1 reference

26 July 2017

40

1 reference

26 July 2017

1

1 reference

26 July 2017

9-13

1 reference

Active-site directed irreversible inhibitors of dihydrofolate reductase

26 July 2017

1

1 reference

10.1002/1097-0142(197707)40:1<9::AID-CNCR2820400104>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197707)40:1%3C9::AID-CNCR2820400104%3E3.0.CO;2-6

14 December 2022

2

35

17

Cashmore

1975

1 reference

10.1002/1097-0142(197707)40:1<9::AID-CNCR2820400104>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197707)40:1%3C9::AID-CNCR2820400104%3E3.0.CO;2-6

14 December 2022

4

36

48

Skeel

1976

1 reference

10.1002/1097-0142(197707)40:1<9::AID-CNCR2820400104>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197707)40:1%3C9::AID-CNCR2820400104%3E3.0.CO;2-6

14 December 2022

5

35

2075

Moertel

1975

1 reference

10.1002/1097-0142(197707)40:1<9::AID-CNCR2820400104>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197707)40:1%3C9::AID-CNCR2820400104%3E3.0.CO;2-6

Phase I studies with Baker's Antifol (BAF) (NSC 139105)

14 December 2022

6

1 reference

10.1002/1097-0142(197707)40:1<9::AID-CNCR2820400104>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(197707)40:1%3C9::AID-CNCR2820400104%3E3.0.CO;2-6

14 December 2022

Identifiers

10.1002/1097-0142(197707)40:1<9::AID-CNCR2820400104>3.0.CO;2-6

1 reference

26 July 2017

1 reference